LYRA
Lyra Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LYRA Filings
Filing Date
Form Description
Form Type
2025-11-25
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-25 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-10
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-10 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-10
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-10 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-14
Form 144 - Report of proposed sale of securities
Ownership
2025-10-14 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-08
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2025-10-08 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
